New facility aligns with ESG principles, enables scale-up of start-up’s fruit juice sugar-reducing tech
Sugar-reduction foodTech start-up Better-Juice, Ltd. launches its first full-capacity manufacturing plant setting the wheels in motion for full commercial production of its proprietary sugar-reducing immobilised enzymes. The new facility will enable the company to fulfill current commissions from juice producers globally, as well as respond to anticipated new demands.
The groundbreaking technology developed by the Israeli start-up produces proprietary beads composed of non-GMO microorganisms that naturally convert the juice’s composition of fruit sugars including sucrose, glucose and fructose into better-for-you prebiotic and other non-digestible fibers.
The new site—located in the Nes Ziona science park south of Tel Aviv—is replete with commercial-scale equipment, including an industrial fermenter and industrial immobilisation processor. The specialised equipment is used for growing and harvesting the beaded microorganisms used in producing Better Juice’s immobilised sugar-reducing enzymes. The site also houses pilot labs and the company’s new headquarters.
The new plant has a production capacity to support sugar-reduction of 250 million liters of juice per year. Better Juice has entered into commitments with a number of juice companies to reduce the sugar loads in various fruit juices, including apple, orange, and pineapple juices.
Better Juice’s technology can reduce up to 80 % of the simple sugar content in fruit juices and fruit-based condiments without any degradation of naturally occurring nutrients, including vitamins, minerals, and antioxidants. It does not dilute the product in a way, maintaining the body and full flavour of the juice and only gently reducing the sweetness. Better Juice’s groundbreaking technology decreases the naturally occurring simple sugar loads in a versatile range of products, including juices, jams, yoghurts, ice creams, sorbets, and more, to the food and beverages manufacturers desired levels.
“This move marks a major leap forward in our commercialisation efforts,” enthuses Gali Yarom, Co-Founder and Co-CEO. “We project that the new plant will accommodate our production needs for the next four years. As interest and demand in our technology continue to flourish in the global fruit juice sphere, we will expand our production capabilities outside of Israel as well.” Wired magazine recently rated Better Juice as one on of the 10 most promising start-ups in Israel.
Better Juice’s facility and operations also maintain high alignment to environmental, social, and corporate governance (ESG) principles. The biodegradable polymer beads are rechanneled to livestock feed after being used in the production phase, minimising waste. The bioreactors, which have a 20-year lifespan, can be controlled remotely, reducing the company’s need for travel and its subsequent carbon footprint. Only a small amount of energy is required to activate the bioreactors. On a social level, the company boasts a 50 % female workforce and assists manufacturers of fruit-based products to comply with the various “sugar tax” regulations in the regions where they operate.
“We had to design and construct specialised systems from scratch to support our unique production processes while taking environmental considerations into account and adhering to the strictest requirements for waste treatment, water recycling, and energy efficiency,” notes Henry Elkoby, Chief Engineer of Better Juice.
“Better Juice was founded with the vision of promoting the overall well-being of people globally,” asserts Eran Blachinsky, co-founder and co-CEO of Better Juice. “The realisation that also naturally squeezed fruit juice can harbor high quantities of simple sugar is what sparked the creation of the Better Juice technology,” adds Blachinsky. “It has been an incredible journey seeing our concept evolve into fruition, and onto the global market so that more people around the world can enjoy the full flavour and nutritional benefits of fruit juices.”
Better Juice was founded in 2018 as one of the first start-ups to be nurtured by The Kitchen FoodTech Hub. “Better Juice brings a new hope for juice manufacturers and consumers, by reversing the perception of natural fruit juices as overly sugary products and turning juices into better-for-you beverages,” says Amir Zaidman, Chief Business Officer of The Kitchen Hub and a Better Juice board member. “The company offers a truly better juice product by reducing the sugars while maintaining their natural profile of vitamins, minerals and fibers.”
Better Juice partners with GEA and US juice maker to commercialise reduced-sugar juices.
FoodTech start-up Better Juice, Ltd. sealed its first commercial deal to bring reduced-sugar juices one step closer to supermarket beverage aisles. The company inked an agreement with a major US fruit juice manufacturer for commercial installment of its sugar-reduction technology.
This is Better Juice’s first official commercial venture in its long-term collaboration with GEA Group, AG, Germany, a world leader in process engineering for the food and beverage sectors. The two companies joined forces in a strategic move to scale up and promote the sugar-reduction technology throughout the global beverage market.
Start-up receives patent and a self-affirmed GRAS approval
Better Juice was granted a patent for its sugar-reduction enzymatic process in Europe. Armed with recent self-affirmed GRAS status, the company is out to market its innovative system to food and beverage manufacturers worldwide. “These achievements, together with GEA’s knowhow and cutting-edge technology, will open doors to work more closely with food and beverage companies,” explains Eran Blachinsky, PhD, co-founder and co-CEO of Better Juice.
Better-Juice’s patented enzymatic technology uses all-natural ingredients to convert fructose, glucose, and sucrose sugars into prebiotic and other non-digestible fibers. The juice passes through a continuous flow bio-reactor housing non-GMO microorganism that transform the unwanted sugars into beneficial, non-digestible molecules. It boasts capabilities to reduce sugar loads by up to 80 %, while preserving the full complement of vitamins and other nutrients inherent in the fruit. The process moderates the sweetness of the juice, while intensifying the fruit flavour.
Sugar-reduced juices will line the shelves next year
Under the new venture, GEA will design, manufacture, and install the bioreactor that reduces sugars, and offer follow-up technical support. Better Juice will produce the microorganisms for the enzymatic process. According to the first commercial order, the fruit drinks manufacturer will produce natural juices with a minimum sugar reduction of 30 %, and anticipates the product to arrive in supermarkets by spring 2022.
“This new agreement marks an exciting milestone in our mission to get our sugar-reduction technology off the ground, to penetrate the US market, and to expand our global footprint,” enthuses Blachinsky. “We’ve officially launched our drive to help consumers enjoy reduce sugar in their favourite fruit juice.”
“Scaling up is always a challenge,” confesses Gali Yarom, co-founder and co-CEO of Better Juice. “But when your partner is GEA, with its vast industrial food processing capabilities and global presence, the acceleration of the Better Juice commercialisation is much faster and brings added value to the supply chain. Imagine—in just a few months, affordable, reduced-sugar fruit juice will be a ready option for American consumers.”
The equipment has been tested in GEA’s quality assurance facility in Germany and can be easily integrated into existing juice production lines, providing product at a capacity of up to 200 liter per hour. Total production capacity of reduced-sugar juices can be adjusted to the manufacturer’s needs.
“Better Juice has incredible potential to transform the global juice industry,” notes Colm O’Gorman, Head of Sales Management for GEA’s Global Technology Center for Non-Alcoholic Beverages. “As consumer demand for lowered-sugar beverages continues to surge, we are eager to join Better Juice on this momentous journey. We look forward to delivering products that address one of the top consumer needs of reducing their sugar intake, especially in daily beverages.”
Tate & Lyle PLC, a leading global provider of food and beverage solutions and ingredients, announced the appointment of William Magee as President, North America, Food & Beverage Solutions, and as a member of Tate & Lyle’s Executive Committee, with effect from 1 October 2021.
William Magee joined Tate & Lyle in April 2018 as Commercial Vice President, North America, Food & Beverage Solutions, before being promoted to Senior Vice President and General Manager, North America, Food & Beverage Solutions later that year. In these positions, he has been instrumental in leading the Company’s growth transformation in the region over the last three years. Prior to joining Tate & Lyle, Bill held senior leadership roles with Rohm & Haas, H.B Fuller and Michelman.
Leading botanical extracts company to produce pharmaceutical grade CBD for the international market, using Italian biomass
Indena, a leading Italian company in international markets, has been authorised by the Italian Ministry of Health and Italian Medicines Agency (AIFA) to produce cannabinoid-based cannabis extracts. Indena will produce pharmaceutical grade cannabidiol (CBD) for the global market for clinical and commercial use.
Indena is the first company in Italy to receive authorisation from the Ministry of Health to manufacture cannabinoid-based cannabis extracts. The approval process continued and Indena has also received authorisation from the AIFA, making it one of the few companies in the world able to produce cannabidiol (CBD) for the pharmaceutical market. CBD is an active ingredient obtained by extraction and isolation from the inflorescences and aerial parts of hemp (Cannabis sativa L.).
With its 100 years of experience in the production of high-end botanical extracts, Indena is well placed to produce high purity CBD. The raw material will be grown and processed in Italy. The supply chain, which complies with the strict criteria set out in the Italian regulations, is controlled, certified and fully traced by the company. Indena’s traditional rigour in managing the production chain was a key factor in obtaining authorisation.
Indena uses registered varieties of hemp with a THC level of less than 0.2 % in accordance with European standards. It also guarantees a residual THC content of less than 0.02 %, well below the limits defined by the FDA (Food and Drug Administration) and by DEA (Drug Enforcement Administration). This approach enabled Indena to promptly submit the DMF (Drug Master File) for this product to the FDA.
“We have been working a long time for this outcome. It is the result of an intense and fruitful collaboration with the Ministry of Health and the AIFA, for the construction of a rigorous approval process to guarantee the safety and control of production, both of the raw material and of the active principle”, says Stefano Togni, Corporate Director for Business Development and Licensing of Indena SpA. “We are aiming at the international pharmaceutical markets. As an Italian company, we are proud to be able to make this totally Italian product of the highest quality available globally, an ingredient expected all over the world for its beneficial effects on a number of pathologies”.
The hemp biomass used by Indena is processed in a pharmaceutical plant that is regularly authorised by AIFA and inspected by the main international regulatory agencies (FDA, KFDA, PMDA and others). All production is carried out in compliance with pharmaceutical GMP (Good Manufacturing Practices), in line with the highest quality standards that the company has always applied which have been recognised by the international scientific community and consolidated over 100 years of business.
Cannabidiol (CBD) is an active pharmaceutical ingredient whose use is approved for seizures associated with some rare forms of childhood epilepsy (Lennox-Gastaud syndrome, Dravet syndrome and tuberous sclerosis complex), and in clinical development for other forms of epilepsy. Furthermore CBD is under clinical investigation for schizophrenia, and for its therapeutic potential in other psychiatric disorders, neurological or autoimmune/inflammatory based diseases1.
Once again, Indena’s focus on quality, scientific rigour and innovation has enabled it to receive recognition from Italy’s top pharmaceutical regulatory institutions. This will enable the company to produce an active principle for which there has been market demand for some time.
1C. Michael White, PharmD, A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and Potential, J Clin Pharmacol 2019, 59(7), 923-934.
Consumers across the world may soon be experiencing tastier, fuller-sized blueberries year-round, thanks to a new breeding partnership in blueberries that will bring premium quality berries to customers across the world.
Plant & Food Research and global fresh produce company T&G Global have announced they are entering into a new agreement to breed and commercialise exciting new varieties of blueberries to be sold globally.
The breeding programme will produce new varieties of blueberry that will provide improved yield and resistance to disease while also delivering consumers larger, tastier berries over a longer period, with an extended harvest season.
The first new commercial varieties could be launched globally in the next 12 months under T&G Global’s Orchard Rd brand.
“Blueberries are a key strategic play for us in building our global portfolio, and we’re delighted to build another global category to emulate the success of our premium apple brands. We know there is strong consumer demand for blueberries and teaming up with Plant & Food Research means we get access to a pipeline of world-class varieties,” says Gareth Edgecombe, CEO of T&G Global.
“Securing exclusive rights to the best varieties is the first step in our strategy to build multiple global verticals that drive and enable value and add demand through strong consumer brands,” he says.
The new partnership builds on an existing agreement that grants the global fresh produce grower and marketer, T&G Global, access to a suite of Plant & Food Research-bred and licensed blueberry varieties for production in Australia.
“Plant & Food Research and T&G Global have a strong relationship that began at their legacy organisations in the 1990s,” says David Hughes, CEO Plant & Food Research.
“T&G has an excellent track record of commercialising our varieties, most notably the apples branded JAZZ™ and Envy™. We are looking forward to continuing building on this history and delivering excellent blueberries for New Zealand and global consumers,” he says.
